SCM
Stonebridge Capital Management Portfolio holdings
AUM
$256M
This Quarter Return
+6.01%
1 Year Return
+15.25%
3 Year Return
+71.85%
5 Year Return
+125.65%
10 Year Return
+234.74%
AUM
$281M
AUM Growth
+$281M
(+5.8%)
Cap. Flow
-$11.7M
Cap. Flow
% of AUM
-4.15%
Top 10 Holdings %
Top 10 Hldgs %
36.05%
Holding
145
New
5
Increased
21
Reduced
65
Closed
6
Top Buys
| 1 |
Gilead Sciences
GILD
|
$939K |
| 2 |
Merck
MRK
|
$727K |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$634K |
| 4 |
Baker Hughes
BKR
|
$514K |
| 5 |
Sabra Healthcare REIT
SBRA
|
$407K |
Top Sells
| 1 |
Qualcomm
QCOM
|
$1.74M |
| 2 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$1.36M |
| 3 |
Chevron
CVX
|
$1.26M |
| 4 |
Schlumberger
SLB
|
$749K |
| 5 |
Boeing
BA
|
$631K |
Sector Composition
| 1 | Technology | 23.72% |
| 2 | Healthcare | 17.32% |
| 3 | Industrials | 14.22% |
| 4 | Energy | 11.1% |
| 5 | Consumer Staples | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Becton Dickinson
BDX
$55.3B
| $1.14M | 0.41% |
5,025
| – | – |
|
|
52
Baker Hughes
BKR
$44.8B
| $1.12M | 0.4% |
30,035
+13,823
| +85% | +$514K |
|
53
Abbott
ABT
$231B
| $1.11M | 0.39% |
18,826
+373
| +2% | +$22K |
|
54
Kimberly-Clark
KMB
$42.8B
| $1.1M | 0.39% |
9,700
| – | – |
|
|
VAR
55
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.06M | 0.38% |
9,724
-615
| -6% | -$66.7K |
|
56
Avery Dennison
AVY
$13.4B
| $944K | 0.34% |
7,908
| – | – |
|
|
RDS.B
57
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $938K | 0.33% |
12,894
| – | – |
|
58
Biogen
BIIB
$19.4B
| $919K | 0.33% |
2,736
-1,738
| -39% | -$584K |
|
|
MON
59
DELISTED
Monsanto Co
MON
| $919K | 0.33% |
7,680
| – | – |
|
|
AGN
60
DELISTED
Allergan plc
AGN
| $824K | 0.29% |
4,682
+1,613
| +53% | +$284K |
|
|
UN
61
DELISTED
Unilever NV New York Registry Shares
UN
| $807K | 0.29% |
14,550
| – | – |
|
62
Palo Alto Networks
PANW
$127B
| $787K | 0.28% |
5,125
-530
| -9% | -$81.4K |
|
63
Estee Lauder
EL
$33B
| $784K | 0.28% |
6,100
-1,300
| -18% | -$167K |
|
64
DuPont de Nemours
DD
$32.2B
| $753K | 0.27% |
9,986
| – | – |
|
65
Invesco
IVZ
$9.76B
| $701K | 0.25% |
18,525
-3,000
| -14% | -$114K |
|
|
66
Sabra Healthcare REIT
SBRA
$4.58B
| $701K | 0.25% |
39,325
+22,825
| +138% | +$407K |
|
|
LLL
67
DELISTED
L3 Technologies, Inc.
LLL
| $701K | 0.25% |
3,348
| – | – |
|
68
Norfolk Southern
NSC
$62.8B
| $686K | 0.24% |
4,445
| – | – |
|
|
69
Regeneron Pharmaceuticals
REGN
$61.5B
| $634K | 0.23% |
+1,728
| New | +$634K |
|
70
National Grid
NGG
$70B
| $631K | 0.22% |
10,964
-1,145
| -9% | -$65.9K |
|
71
Wells Fargo
WFC
$263B
| $629K | 0.22% |
10,051
-1,200
| -11% | -$75.1K |
|
|
SJR
72
DELISTED
Shaw Communications Inc.
SJR
| $622K | 0.22% |
28,525
| – | – |
|
73
Conagra Brands
CAG
$9.16B
| $620K | 0.22% |
16,900
+4,850
| +40% | +$178K |
|
74
Vertex Pharmaceuticals
VRTX
$100B
| $588K | 0.21% |
3,722
-225
| -6% | -$35.5K |
|
75
Bristol-Myers Squibb
BMY
$96B
| $558K | 0.2% |
8,892
-2,500
| -22% | -$157K |
|